TP am i the only one who saw that post by akamali from the report by cubisin about dapto falling behind in sales that quarter and the reason given that patients were not enamoured by the way it is administered and the time it took. besides they quoted a billion dollars in sales at their high point i think. that's the figure leo uses.
that is better news than the u of bologna validating the efficacy of kevetrin by asking for a formulation at 75 or below.